Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-251 MG

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 201-208

  Shirato, Ken ^a   Imaizumi, Kazuhiko ^a   Abe, Akihisa ^b   Tomoda, Akio ^b  

^a WASEDA UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

2 Amino 4,4 dihydro 4 ,7 dimethyl 3H phenoxazine 3 one; 2 Aminophenoxazine 3 one; Apoptosis; Caspase; Glioblastoma

Indexed keywords

2 AMINO 4,4ALPHA DIHYDRO 4ALPHA,7 DIMETHYL 3H PHENOXAZINE 3 ONE; 2-AMINO-4,4ALPHA-DIHYDRO-4ALPHA,7-DIMETHYL-3H-PHENOXAZINE-3-ONE; 3 AMINOPHENOXAZONE; 3-AMINOPHENOXAZONE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CYSTEINE PROTEINASE INHIBITOR; OXAZINE DERIVATIVE; PEPTIDE CHLOROMETHYL KETONE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; GLIOBLASTOMA; HUMANS; OXAZINES;

EID: 37849034337     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.201     Document Type: Article

References (36)

1. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990. (Pubitemid 20373997)
2. Sen S and D'Incarci M: Apoptosis: biochemical events and relevance to cancer thermotherapy. Fed Eur Biochem Socie 307: 122-127, 1992.
3. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 298: 1312-1316, 1998. (Pubitemid 28406817)
4. Green D and Kroemer G: The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8: 267-271, 1998. (Pubitemid 28310224)
5. Lorenzo HK, Susin SA, Penninger J and Kroemer G: Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6: 516-524, 1999. (Pubitemid 29292107)
6. Hail N Jr, Carter BZ, Konopleva M and Andreeff M: Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11: 889-904, 2006. (Pubitemid 43880261)
7. Vande Velde C, Cizeu J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000. (Pubitemid 30482883)
8. Hong SJ, Dawson TM and Dawson VL: Nuclear and mitochondrial conversation in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 25: 259-264, 2004. (Pubitemid 38553828)
9. Park SY, Cho SJ, Kwon HC, Lee KR, Rhee DK and Pyo S: Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett 224: 123-132, 2005.
10. Tomoda A, Arai S, Ishida R, Shimamoto T and Ohyashiki K: An improved method for the rapid preparation of a novel antitumor agent. Biorg Med Chem Lett 11: 1057-1058, 2002.
11. Shimizu S, Suzuki M, Tomoda A, Arai S, Taguchi H, Hanawa T and Kamiya S: Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med 203: 47-52, 2004. (Pubitemid 38832654)
12. Shimamoto T, Tomoda A, Ishida R and Ohyashiki K: Antitumor effects of novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin Cancer Res 7: 704-708, 2001. (Pubitemid 32707997)
13. Abe A, Yamane M and Tomoda A: Prevention of growth of human lung carcinoma cells and induction of apoptosis by a novel phenoxazine, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one. Anticancer Drugs 12: 377-381, 2001.
14. Shimizu S, Suzuki M, Miyazawa K, Yokoyama T, Ohyashiki K, Miyazaki K, Abe A and Tomoda A: Differentiation and apoptosis in human malignant melanoma G-361 cells induced by 2-amino-phenoxazine-3-one. Oncol Rep 14: 41-46, 2005.
15. Koshibu-Koizumi J, Akazawa M, Iwamoto T, Takasaki M, Mizuno F, Kobayashi R, Abe A, Tomoda T, Hamatake M and Ishida R: Antitumor activity of a phenoxazine compound, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis and necrosis. J Cancer Res Clin Oncol 128: 363-368, 2002. (Pubitemid 34824178)
16. Kato S, Shirato K, Imaizumi K, Toyoda H, Mizuguchi J, Odawara M, Che XF, Akiyama S, Abe A and Tomoda A: Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep 15: 843-848, 2006.
17. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)
18. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
19. Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofe-Ochoa X, Totzke F, Schachtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J and Meijer L: 7-Bromoindirubin-3′-oxime induces caspase-independent cell death. Oncogene 25: 6304-6318, 2006. (Pubitemid 44564746)
20. Tobey RA: Different drugs arrest cells at a number of distinct stages in G2. Nature 254: 245-247, 1975.
21. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689, 1997. (Pubitemid 27464966)
22. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999. (Pubitemid 29165088)
23. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998. (Pubitemid 28524494)
24. Enoki E, Sada K, Qu X, Kyo S, Shahjahan Miah SM, Hatani T, Tomoda A and Yamamura Y: The phenoxazine derivative Phx-1 suppresses IgE-mediated degranulation in rat basophilic leukemia RBL 2H3 cells. J Pharmacol Sci 94: 329-333, 2004.
25. Hara K, Okamoto M, Aki T, Yagita H, Tanaka H, Mizukami Y, Nakamura H, Tomoda A, Hamasaki N and Kang D: Synergistic enhancement of TRAIL- and TNFα-induced cell death by a phenoxazine derivative. Mol Cancer Ther 4: 1121-1127, 2005.
26. Hollstein U: Actinomycin. Chemistry and mechanism of action. Chem Rev 74: 625-652, 1974.
27. Mori H, Honda K, Ishida R, Nohira T and Tomoda A: Antitumor activity of 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine- 3-one against Meth A tumor transplanted into BALB/c mice. Anticancer Drugs 11: 653-657, 2000.
28. Gao S, Takano T, Sada K, Tomoda A and Yamamura H: A novel phenoxazine derivative suppresses surface IgM expression in DT40B cell line. Br J Pharmacol 137: 749-755, 2002.
29. Iwata A, Yamaguchi T, Sato K, Yoshitake N and Tomoda A: Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazine, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4α-dihydro-4α,8-dimethyl-2H-phenoxazine-2-one. Biol Pharm Bull 28: 905-907, 2005.
30. Uruma T, Yamaguchi H, Fukuda M, Kawakami H, Goto H, Kishimoto T, Yamamoto Y, Tomoda A and Kamiya S: Clamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative. J Med Microbiol 54: 1143-1149, 2005.
31. Musha S, Watanabe M, Ishida Y, Kato S, Konishi M and Tomoda A: A phenoxazine compound, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H- phenoxazine-3-one reverses the phenylephrine or high-K+ induced contraction of smooth muscles in rat aorta and Guinea pig tenia cecum. Biol Pharm Bull 28: 1521-1523, 2005.
32. Lefranc F, Brotchi J and Kiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422, 2005.
33. Lassman AB: Molecular biology of gliomas. Curr Neural Neurosci Rep 4: 228-233, 2004.
34. Dai C, Lyustikman Y, Shih A, Hu X, Fuller GN, Rosenblum M and Holland EC: The characteristics of astrocytoma and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia 7: 397-406, 2005.
35. Butowski NA, Sneed PK and Chang SM: Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24: 1273-1280, 2006.
36. Azuine MA, Tokuda H, Takayasu J, Enjyo F, Mukainaka T, Konoshima T, Nishino H and Kapadia GF: Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Pharmacol Res 49: 161-169, 2004.